Inventor · disambiguated record
Xiaojun Han
Also filed as: HAN XIAOJUN
15 granted patents·4 pending applications·81 citations·filing 2003–2022
91Inventor score
Top patents by PatentIndex Score
19 records- 0191US10266578B2Modified relaxin polypeptides comprising a pharmacokinetic enhancer and uses thereofBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Apr 23, 2019·9 cites·30 claims
- 0288US7834007B2CGRP antagonistsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Nov 16, 2010·9 cites·10 claims
- 0388US7314883B2Anti-migraine treatmentsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Jan 1, 2008·12 cites·36 claims
- 0487US7842808B2Anti-migraine spirocyclesBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Nov 30, 2010·13 cites·36 claims
- 0586US7772244B2Therapeutic agents for the treatment of migraineBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Aug 10, 2010·12 cites·14 claims
- 0679US12097242B2Treatment of fibrosis, cardiovascular disease and heart failure with modified relaxin polypeptidesBRISTOL MYERS SQUIBB CO·Filed 2022·Granted Sep 24, 2024·0 cites·26 claims
- 0779US10968219B23-substituted propionic acids as αV integrin inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Apr 6, 2021·2 cites·16 claims
- 0879US7244746B2Imidazolyl derivatives as corticotropin releasing factor inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Jul 17, 2007·9 cites·16 claims
- 0979US7220862B2Calcitonin gene related peptide receptor antagonistsBRISTOL MYERS SQUIBB CO·Filed 2003·Granted May 22, 2007·11 cites·36 claims
- 1078US12097241B2Methods of treating kidney failure, and/or improving or stablizing renal function using modified relaxin polypeptidesBRISTOL MYERS SQUIBB CO·Filed 2022·Granted Sep 24, 2024·0 cites·17 claims
- 1175US11364281B2Modified relaxin polypeptides comprising a pharmacokinetic enhancer and pharmaceutical compositions thereofBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Jun 21, 2022·0 cites·2 claims
- 1274US11185570B2Method of treating cardiovascular disease and heart failure with modified relaxin polypeptidesBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Nov 30, 2021·0 cites·20 claims
- 1371US7470680B2Constrained compounds as CGRP-receptor antagonistsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Dec 30, 2008·1 cites·9 claims
- 1470US7125990B2Imidazolyl derivatives as corticotropin releasing factor inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Oct 24, 2006·3 cites·17 claims
- 1561US11884661B23-substituted propionic acids as αV integrin inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Jan 30, 2024·0 cites·11 claims
- 1653US2023312556A1Arylamide compound, pharmaceutical composition comprising same, and preparation method therefor and use thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 1751US2025268897A1Use of heterocyclic compound in treating diseases related to kinase drug-resistant mutation and method thereforSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 1847US2004063735A1Calcitonin gene related peptide receptor antagonistsFiled 2003·Application pending·0 cites
- 1942US2022144847A1Heterocyclic compound, pharmaceutical composition comprising same, preparation method therefor, and use thereofSICHUAN KELUN BIOTECH BIOPHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Xiaojun Han files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →